Bentos, John Mark H.

HRN: 25-41-06  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/30/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/30/2024
07/06/2024
IV INFUSION
1.5gm
Q6
T/c Tetanus Infection
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: